Polman CH - Search Results

1

Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.

Hintzen RQ, van Lier RA, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH. Hintzen RQ, et al. Among authors: polman ch. J Neuroimmunol. 1991 Dec;35(1-3):211-7. doi: 10.1016/0165-5728(91)90175-7. J Neuroimmunol. 1991. PMID: 1659587

2

Functional defects in peripheral blood T cells of multiple sclerosis patients. Diminished in vitro responsiveness in accessory cell dependent activation systems.

Rep MH, Hintzen RQ, Polman CH, van Lier RA. Rep MH, et al. Among authors: polman ch. J Neuroimmunol. 1994 Jul;52(2):139-46. doi: 10.1016/0165-5728(94)90107-4. J Neuroimmunol. 1994. PMID: 8034753

3

Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells.

Rep MH, Hintzen RQ, Polman CH, van Lier RA. Rep MH, et al. Among authors: polman ch. J Neuroimmunol. 1996 Jul;67(2):111-8. doi: 10.1016/0165-5728(96)00060-4. J Neuroimmunol. 1996. PMID: 8765333

4

A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis.

van Oosten BW, Rep MH, van Lier RA, Scholten PE, von Blomberg BM, Pflughaupt KW, Hartung HP, Adèr HJ, Polman CH. van Oosten BW, et al. Among authors: polman ch. J Neuroimmunol. 1996 May;66(1-2):49-55. doi: 10.1016/0165-5728(96)00019-7. J Neuroimmunol. 1996. PMID: 8964913 Clinical Trial.

5

Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.

Rep MH, Schrijver HM, van Lopik T, Hintzen RQ, Roos MT, Adèr HJ, Polman CH, van Lier RA. Rep MH, et al. Among authors: polman ch. J Neuroimmunol. 1999 Apr 1;96(1):92-100. doi: 10.1016/s0165-5728(98)00271-9. J Neuroimmunol. 1999. PMID: 10227428 Clinical Trial.

6

Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta.

Killestein J, Hintzen RQ, Uitdehaag BM, Baars PA, Roos MT, van Lier RA, Polman CH. Killestein J, et al. Among authors: polman ch. J Neuroimmunol. 2002 Dec;133(1-2):217-24. doi: 10.1016/s0165-5728(02)00373-9. J Neuroimmunol. 2002. PMID: 12446026

7

Multiple sclerosis: immunological findings and possible implications for therapy.

Hintzen RQ, Polman CH, Lucas CJ, van Lier RA. Hintzen RQ, et al. Among authors: polman ch. J Neuroimmunol. 1992 Jul;39(1-2):1-10. doi: 10.1016/0165-5728(92)90169-l. J Neuroimmunol. 1992. PMID: 1377708 Review. No abstract available.

8

Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals.

Hintzen RQ, Fiszer U, Fredrikson S, Rep M, Polman CH, van Lier RA, Link H. Hintzen RQ, et al. Among authors: polman ch. J Neuroimmunol. 1995 Jan;56(1):99-105. doi: 10.1016/0165-5728(94)00137-d. J Neuroimmunol. 1995. PMID: 7822487

9

Magnetic resonance imaging studies in multiple sclerosis twins.

Uitdehaag BM, Polman CH, Valk J, Koetsier JC, Lucas CJ. Uitdehaag BM, et al. Among authors: polman ch. J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1417-9. doi: 10.1136/jnnp.52.12.1417. J Neurol Neurosurg Psychiatry. 1989. PMID: 2614439 Free PMC article.

10

Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjects.

van Noort JM, van Sechel A, Boon J, Boersma WJ, Polman CH, Lucas CJ. van Noort JM, et al. Among authors: polman ch. J Neuroimmunol. 1993 Jul;46(1-2):67-72. doi: 10.1016/0165-5728(93)90234-p. J Neuroimmunol. 1993. PMID: 8360332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters